[Antimicrobial susceptibility in Pseudomonas aeruginosa strains taken from patients with cystic fibrosis]. / Susceptibilidad antimicrobiana en cepas de Pseudomonas aeruginosa procedentes de pacientes con fibrosis quística.
Rev Cubana Med Trop
; 58(3): 207-11, 2006.
Article
em Es
| MEDLINE
| ID: mdl-23424788
Ninety strains of Pseudomonas aeruginosa isolated from pediatric patients with cystic fibrosis and respiratory infections at "William Soler" pediatric hospital were studied in the period from February to August, 2001, as part of a joint research project of the two hospitals. In vitro susceptibility of these strains to 10 antimicrobials, that is, azlocylline, ceftazidime, cefotaxime, ceftriaxone, gentamicin, tetracycline, ciprofloxacine, ofloxacine, chloranphenicol and trimethroprim/sulfamet-hoxazole was studied by Kirby-Bauer disk diffusion. The reference strain was ATCC 27853. The research work results showed that antimicrobial susceptibility values were within the allowable limits. Increased resistance to chloranphenicol (87.03%) and trimethoprim/sulfametoxazole (92.28%) as well as high sensitivity to azlocylline (85%), ceftazidime (87.09%), gentamicyn (94.09%), ciprofloxacine (94.8%) and ofloxacine (92.5%) were observed.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pseudomonas aeruginosa
/
Infecções por Pseudomonas
/
Portador Sadio
/
Fibrose Cística
/
Farmacorresistência Bacteriana Múltipla
Tipo de estudo:
Etiology_studies
Limite:
Child
/
Humans
País/Região como assunto:
Caribe
/
Cuba
Idioma:
Es
Revista:
Rev Cubana Med Trop
Ano de publicação:
2006
Tipo de documento:
Article
País de publicação:
Cuba